Systemic delivery of lentivirus-mediated secretable TAT-apoptin eradicates hepatocellular carcinoma xenografts in nude mice

International Journal of Oncology

Volumn 41, Issue 3, 2012, Pages 1013-1020

  Ma, Jin Lu ^a   Han, Su Xia ^a   Zhao, Jing ^a   Zhang, Dan ^a   Wang, Li ^a   Li, Yao Dong ^b   Zhu, Qing ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b XI'AN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptin; Hepatocellular carcinoma; Lentivirus; Nude mice; TAT PTD

Indexed keywords

APOPTIN; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; SIGNAL PEPTIDE; TRANSACTIVATOR PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TUMOR XENOGRAFT; VIRUS PARTICLE;

ANIMALS; APOPTOSIS; CAPSID PROTEINS; CARCINOMA, HEPATOCELLULAR; CELL LINE; GENETIC THERAPY; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LENTIVIRUS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED ICR; MICE, NUDE; RANDOM ALLOCATION; RECOMBINANT FUSION PROTEINS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84864983448     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1547     Document Type: Article

References (16)

1. Noteborn MH and van der Eb AJ: Apoptin-induced apoptosis: potential for antitumor therapy. Drug Resist Updat 1: 99-103, 1998.
2. Los M, Panigrahi S, Rashedi I, Mandal S, Stetefeld J, Essmann F, et al: Apoptin, a tumor-selective killer. Biochim Biophys Acta 1793: 1335-1342, 2009.
3. Russo A, Terrasi M, Agnese V, Santini D and Bazan V: Apoptosis: a relevant tool for anticancer therapy. Ann Oncol 17: vii115-23, 2006. (Pubitemid 43985192)
4. Alvisi G, Poon IK and Jans DA: Tumor-specific nuclear targeting: promises for anti-cancer therapy? Drug Resist Updat 9: 40-50, 2006. (Pubitemid 43928804)
5. Maddika S, Mendoza FJ, Hauff K, Zamzow CR, Paranjothy T and Los M: Cancer-selective therapy of the future: apoptin and its mechanism of action. Cancer Biol Ther 5: 10-19, 2006. (Pubitemid 43234971)
6. Poon IK, Oro C, Dias MM, Zhang JP and Jans DA: A tumor cell-specific nuclear targeting signal within chicken anemia virus VP3/apoptin. J Virol 79: 1339-1341, 2005. (Pubitemid 40053918)
7. Chauhan A, Tikoo A, Kapur AK and Singh M: The taming of the cell penetrating domain of the HIV Tat: myths and realities. J Control Release 117: 148-162, 2007. (Pubitemid 46172502)
8. Dietz GP and Bahr M: Delivery of bioactive molecules into the cell: the Trojan horse approach. Mol Cell Neurosci 27: 85-131, 2004. (Pubitemid 39370094)
9. Wang H, Zhong CY, Wu JF, Huang YB and Liu CB: Enhancement of TAT cell membrane penetration efficiency by dimethyl sulphoxide. J Control Release 143: 64-70, 2010.
10. Flinterman M, Farzaneh F, Habib N, Malik F, Gaken J and Tavassoli M: Delivery of therapeutic proteins as secretable TAT fusion products. Mol Ther 17: 334-342, 2009.
11. Guelen L, Paterson H, Gaken J, Meyers M, Farzaneh F and Tavassoli M: TAT-apoptin is efficiently delivered and induces apoptosis in cancer cells. Oncogene 23: 1153-1165, 2004. (Pubitemid 38269969)
12. Han SX, Ma JL, Lv Y, Huang C, Liang HH and Duan KM: Secretory Transactivating Transcription-apoptin fusion protein induces apoptosis in hepatocellular carcinoma HepG2 cells. World J Gastroenterol 14: 3642-3649, 2008.
13. Han SX, Zhao J, Ma JL, Huang C, Lu Y, Ou W, et al: The effect of the fused gene of SP-TAT-Apoptin transfected by lentivirus on HepG2 cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 26: 310-312, 2010 (In Chinese).
14. Barash S, Wang W and Shi Y: Human secretory signal peptide description by hidden Markov model and generation of a strong artificial signal peptide for secreted protein expression. Biochem Biophys Res Commun 294: 835-842, 2002. (Pubitemid 34687192)
15. Lippincott-Schwartz J, Yuan LC, Bonifacino JS and Klausner RD: Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER. Cell 56: 801-813, 1989. (Pubitemid 19082516)
16. Pelletier L, Jokitalo E and Warren G: The effect of Golgi depletion on exocytic transport. Nat Cell Biol 2: 840-846, 2000.